MTNB Stock Summary and Trading Ideas (Matinas Biopharma Hldgs | AMEX:MTNB)

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Matinas Biopharma Hldgs trades on the AMEX stock market under the symbol MTNB.

As of January 22, 2025, MTNB stock price declined to $0.57 with 72,136 million shares trading.

MTNB has a beta of -7.78, meaning it tends to be less sensitive to market movements. MTNB has a correlation of 0.06 to the broad based SPY ETF.

MTNB has a market cap of $2.92 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, MTNB traded as high as $4.49 and as low as $.09.

The top ETF exchange traded funds that MTNB belongs to (by Net Assets): VXF, VTI.

MTNB has outperformed the market in the last year with a return of +188.3%, while the SPY ETF gained +27.2%. However, in the most recent history, MTNB shares have underperformed the stock market with its stock returning -84.6% in the last 3 month period and -40.2% for the last 2 week period, while SPY has returned +4.2% and +3.0%, respectively.

MTNB support price is $.52 and resistance is $.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MTNB shares will trade within this expected range on the day.